Learn how Mayo Clinic Laboratories testing for adrenal diseases can help physicians detect and classify adrenal disorders.
MCL Benign Hematology Test Request MC076707A
MCL Benign Hematology Test Request Complete print Reset Form Benign Hematology Test Request Client Information required Client Patient Information required Patient ID Medical
ulcerative-colitis-crohn-disease-therapeutic-drug-monitoring-algorithm.pdf
No enzyme activity Thiopurine therapy contraindicated Decreased enzyme activity Reduced thiopurine dosing appropriate Normal enzyme activity Appropriate for weight-based dosing Diagnosis of ulcerative colitis (UC) or Crohn disease...
New tests launched in January - Insights
In January 2023, Mayo Clinic Laboratories announced fifty-nine new tests along with numerous reference value changes, obsolete tests, and algorithm changes.
thyroid_function_ordering_algorithm.pdf
10/2021© Mayo Foundation for Medical Education and Research (MFMER). All rights reserved. Thyroid Function Ordering Algorithm* Nonhospitalized patients without known or suspected pituitary disease Begin evaluation by ordering either the...
HIV-1 Ab Negative HIV-2 Ab Negative HIV-1 RNA Negative HIV-2 RNA Negative HIV-1 Ab Negative HIV-2 Ab Indeterminate HIV-1 RNA Negative HIV-2 RNA Positive HIV-1 Ab Indeterminate HIV-2 Ab Indeterminate HIV-1 RNA Positive HIV-2 RNA...
MCL Microbiology Test Request MC0767
MCL Microbiology Test Request Complete print Reset Form Microbiology Test Request Client Information required Client Patient Information required Patient ID Medical Record
Our pharmacogenomics (PGx) testing, which is used to inform medication selection and dosing, has the potential to revolutionize medication selection for individuals with treatment-resistant depression.
Our pharmacogenomics (PGx) testing, which is used to inform medication selection and dosing, has the potential to revolutionize medication selection for individuals with treatment-resistant depression.
Our pharmacogenomics (PGx) testing, which is used to inform medication selection and dosing, has the potential to revolutionize medication selection for individuals with treatment-resistant depression.